How do we measure a residual tumor size in Histopathology (the gold standard) after neoadjuvant chemotherapy?

Breast

Volumn 15, Issue 3, 2006, Pages 370-376

  Apple, S K ^a   Suthar, F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer; Neoadjuvant chemotherapy; Tumor size

Indexed keywords

CYTOTOXIN; DOCETAXEL; DOXORUBICIN; TRASTUZUMAB;

ACCURACY; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER SIZE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MINIMAL RESIDUAL DISEASE; PATHOLOGIST; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIODIAGNOSIS; STANDARDIZATION;

EID: 33744939726     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2005.08.002     Document Type: Article

References (16)

1. Londero V., Bazzocchi M., Del Frate C., Puglisi F., Di Loreto C., Francescutti G., et al. Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy. Eur Radiol 14 (2004) 1371-1379
2. Dash N., Chafin S.H., Johnson R.R., and Contractor F.M. Usefulness of tissue marker clips in patients undergoing neoadjuvant chemotherapy for breast cancer. Am J Roentgenol 173 (1999) 911-917
3. Fisher B., Brown A., Mamounas E., Wieand S., Robidoux A., Margolese R.G., et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 15 (1997) 2483-2493
4. Vinnicombe S.J., MacVicar A.D., Guy R.L., Sloane J.P., Powles T.J., Knee G., et al. Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation. Radiology 198 (1996) 333-340
5. Feldman L.D., Hortobagyi G.N., Buzdar A.U., Ames F.C., and Blumenschein G.R. Pathological assessment of response to induction chemotherapy in breast cancer. Cancer Res 46 (1986) 2578-2581
6. Fisher E.R., Wang J., Bryant J., Fisher B., Mamounas E., and Wolmark N. Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18. Cancer 95 (2002) 681-695
7. Cristofanilli M., Gonzalez-Angulo A., Sneige N., Kau S.W., Broglio K., Theriault R.L., et al. Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes. J Clin Oncol 23 (2005) 41-48
8. Cocquyt V.F., Blondeel P.N., Depypere H.T., Praet M.M., Schelfhout V.R., Silva O.E., et al. Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma. Eur J Surg Oncol 29 (2003) 361-367
9. Rosen E.L., Blackwell K.L., Baker J.A., Soo M.S., Bentley R.C., Yu D., et al. Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. Am J Roentgenol 181 (2003) 1275-1282
10. Chen X., Moore M.O., Lehman C.D., Mankoff D.A., Lawton T.J., Peacock S., et al. Combined use of MRI and PET to monitor response and assess residual disease for locally advanced breast cancer treated with neoadjuvant chemotherapy. Acad Radiol 11 (2004) 1115-1124
11. Warren R.M., Bobrow L.G., Earl H.M., Britton P.D., Gopalan D., Purushotham A.D., et al. Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy?. Br J Cancer 90 (2004) 1349-1360
12. Abraham D.C., Jones R.C., Jones S.E., Cheek J.H., Peters G.N., Knox S.M., et al. Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging. Cancer 78 (1996) 91-100
13. Schwartz G.F., and Hortobagyi G.N. Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast, April 26-28, 2003, Philadelphia, Pennsylvania. Breast J 10 (2004) 273-294
14. Moore G.H., Schiller J.E., and Moore G.K. Radiation-induced histopathologic changes of the breast: the effects of time. Am J Surg Pathol 28 (2004) 47-53
15. Chan J. Chemotherapy- and hormone-induced histologic changes in tumours. Curr Diagn Pathol 9 (2003) 137-147
16. van der Hage J.A., van de Velde C.J., Julien J.P., Tubiana-Hulin M., Vandervelden C., and Duchateau L. Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol 19 (2001) 4224-4237